YC137
Product Specifications
UNSPSC Description
YC137 is a potent Bcl-2 antagonist with Kis of 1.3 μM and >100 μM for Bcl-2 and Bcl-xL when assayed in Bis-Tris buffer, respectively. YC137 inhibits the binding of the Bid BH3 peptide to Bcl-2, thus disrupting an interaction essential for the antiapoptotic activity of Bcl-2. YC137 selectively induces apoptosis of Bcl-2-dependent cells. YC137 has the potential for breast cancer research[1][2].
Target Antigen
Apoptosis; Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/yc137.html
Smiles
CSCC[C@@H](C(OC1=CC=C(NC2=NC(C3=O)=C(C(C4=C3C=CC=C4)=O)S2)C=C1)=O)NC(OC)=O
Molecular Weight
511.57
References & Citations
[1]YC137 was solubilized at 10 mmol/L in dimethylsulfoxide and kept at 20°C in the dark until use.|[2]Rie Nishi, et al. Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line. Cancer Sci. 2013 Apr;104(4):502-7.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-123244/YC137-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-123244/
Clinical Information
No Development Reported
CAS Number
810659-53-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Human anti-Glutamate [NMDA] receptor subunit zeta-1 antibody ELISA kit](https://cdn.genprice.uk/genprice/genprice4.png)
E01A4164-01 48 Well
Human anti-Glutamate [NMDA] receptor subunit zeta-1 antibody ELISA kit
Ask
View Details E01A4164-02 96 Well
Human anti-Glutamate [NMDA] receptor subunit zeta-1 antibody ELISA kit
Ask
View Details